BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

637 related articles for article (PubMed ID: 9293482)

  • 1. Effects on interstitial glutathione, cysteine and 5-S-cysteinyldopa of buthionine sulphoximine in human melanoma transplants.
    Dizdar N; Kullman A; Kågedal B; Arstrand K
    Melanoma Res; 1997 Aug; 7(4):322-8. PubMed ID: 9293482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of N-acetylcysteine and l-2-oxothiazolidine-4-carboxylate as cysteine deliverers and glutathione precursors in human malignant melanoma transplants in mice.
    Dizdar N; Kullman A; Kågedal B
    Cancer Chemother Pharmacol; 2000; 45(3):192-8. PubMed ID: 10663636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cysteine-dependent 5-S-cysteinyldopa formation and its regulation by glutathione in normal epidermal melanocytes.
    Benathan M; Labidi F
    Arch Dermatol Res; 1996 Oct; 288(11):697-702. PubMed ID: 8931873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanin content and downregulation of glutathione S-transferase contribute to the action of L-buthionine-S-sulfoximine on human melanoma.
    Fruehauf JP; Zonis S; al-Bassam M; Kyshtoobayeva A; Dasgupta C; Milovanovic T; Parker RJ; Buzaid AC
    Chem Biol Interact; 1998 Apr; 111-112():277-305. PubMed ID: 9679561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutathione depletion by buthionine sulfoximine induces DNA deletions in mice.
    Reliene R; Schiestl RH
    Carcinogenesis; 2006 Feb; 27(2):240-4. PubMed ID: 16162646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective and synergistic activity of L-S,R-buthionine sulfoximine on malignant melanoma is accompanied by decreased expression of glutathione-S-transferase.
    Fruehauf JP; Zonis S; al-Bassam M; Kyshtoobayeva A; Dasgupta C; Milovanovic T; Parker RJ; Buzaid AC
    Pigment Cell Res; 1997 Aug; 10(4):236-49. PubMed ID: 9263331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of glutathione in protection against noise-induced hearing loss.
    Yamasoba T; Nuttall AL; Harris C; Raphael Y; Miller JM
    Brain Res; 1998 Feb; 784(1-2):82-90. PubMed ID: 9518561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of 5-S-cysteinyldopa formation by tyrosinase activity and intracellular thiols in human melanoma cells.
    Benathan M
    Melanoma Res; 1996 Jun; 6(3):183-9. PubMed ID: 8819121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The utilization of N-acetylcysteine and 2-oxothiazolidine-4-carboxylate by rat hepatocytes is limited by their rate of uptake and conversion to cysteine.
    Banks MF; Stipanuk MH
    J Nutr; 1994 Mar; 124(3):378-87. PubMed ID: 8120657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutathione precursor and antioxidant activities of N-acetylcysteine and oxothiazolidine carboxylate compared in in vitro studies of HIV replication.
    Raju PA; Herzenberg LA; Herzenberg LA; Roederer M
    AIDS Res Hum Retroviruses; 1994 Aug; 10(8):961-7. PubMed ID: 7811547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased metal tolerance in Salix by nicotinamide and nicotinic acid.
    Ohlsson AB; Landberg T; Berglund T; Greger M
    Plant Physiol Biochem; 2008 Jul; 46(7):655-664. PubMed ID: 18524611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of modulators of glutathione synthesis on the hepatotoxicity of 2-methylfuran.
    Ravindranath V; Boyd MR
    Biochem Pharmacol; 1991 May; 41(9):1311-8. PubMed ID: 2018563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-Buthionine (S,R) sulfoximine depletes hepatic glutathione but protects against ethanol-induced liver injury.
    Donohue TM; Curry-McCoy TV; Todero SL; White RL; Kharbanda KK; Nanji AA; Osna NA
    Alcohol Clin Exp Res; 2007 Jun; 31(6):1053-60. PubMed ID: 17428293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of intracellular glutathione promotes lymphocyte activation by mitogen.
    Fidelus RK; Tsan MF
    Cell Immunol; 1986 Jan; 97(1):155-63. PubMed ID: 3742607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo selective modulation of tissue glutathione in a rat mammary carcinoma model.
    Baruchel S; Wang T; Farah R; Jamali M; Batist G
    Biochem Pharmacol; 1995 Oct; 50(9):1505-8. PubMed ID: 7503802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo comparison between the effects of treatment with adenosine triphosphate and treatment with buthionine sulfoximine on chemosensitization and tumour growth of B16 melanoma.
    Palomares T; Bilbao P; del Olmo M; Castro B; Calle Y; Alonso-Varona A
    Melanoma Res; 1999 Jun; 9(3):233-42. PubMed ID: 10465578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with the cysteine precursor l-2-oxothiazolidine-4-carboxylate (OTC) implicates taurine deficiency in severity of dystropathology in mdx mice.
    Terrill JR; Boyatzis A; Grounds MD; Arthur PG
    Int J Biochem Cell Biol; 2013 Sep; 45(9):2097-108. PubMed ID: 23892094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulatory effect of glutathione status and antioxidants on methylmercury-induced free radical formation in primary cultures of cerebral astrocytes.
    Shanker G; Syversen T; Aschner JL; Aschner M
    Brain Res Mol Brain Res; 2005 Jun; 137(1-2):11-22. PubMed ID: 15950756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage glutathione content and glutathione peroxidase activity are inversely related to cell-mediated oxidation of LDL: in vitro and in vivo studies.
    Rosenblat M; Aviram M
    Free Radic Biol Med; 1998 Jan; 24(2):305-17. PubMed ID: 9433906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-regulation of melanin precursors and tyrosinase in human pigment cells: roles of cysteine and glutathione.
    Benathan M; Virador V; Furumura M; Kobayashi N; Panizzon RG; Hearing VJ
    Cell Mol Biol (Noisy-le-grand); 1999 Nov; 45(7):981-90. PubMed ID: 10644002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.